Skip to main content

Theratechnologies (TH-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 4.64
Day High 4.89
Open:4.80
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Theratechnologies Inc is a specialty pharmaceutical company which addresses unmet medical needs of HIV patients. The firm mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Theratechnologies' CFO to Attend Stifel Healthcare Conference in New York City
- GlobeNewswire - Thu Nov 14, 2:28PM CST
GlobeNewswire - CMTX
Thu Nov 14, 2:28PM CST
Theratechnologies Inc. (Theratechnologies) (TSX: TH), a commercial-stage biopharmaceutical company, is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend the Stifel Healthcare Conference which will be held in New York City on November 19, 2019.
Trogarzo(R) Remains Effective Close to a Decade After Treatment Initiation
- Globe Newswire - Thu Nov 7, 6:30AM CST
Globe Newswire - CMTX
Thu Nov 7, 6:30AM CST
MONTREAL, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that data presented at the 17th European AIDS Conference, currently being held in Basel, Switzerland, demonstrate that Trogarzo(R) (ibalizumab-uiyk) remains safe and effective in patients having been on treatment for almost a decade.
Theratechnologies Provides Details About R&D Day Webcast
- GlobeNewswire - Mon Oct 21, 6:30AM CDT
GlobeNewswire - CMTX
Mon Oct 21, 6:30AM CDT
Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ: THTX) (TSX: TH), a commercial-stage pharmaceutical company addressing unmet medical needs for people with orphan medical conditions, including those living with HIV, is pleased to provide details about the webcast of its R&D Day.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 4.26 +10.56% increase
on 10/18/19
Period Open:4.85
Price movement based on the high, low and last over the given period.
5.46 -13.74% decrease
on 10/24/19
-0.14 (-2.89%) decrease
since 10/15/19
3-Month 4.26 +10.56% increase
on 10/18/19
Period Open:5.41
Price movement based on the high, low and last over the given period.
6.02 -21.76% decrease
on 09/20/19
-0.70 (-12.94%) decrease
since 08/15/19
52-Week 4.26 +10.56% increase
on 10/18/19
Period Open:7.22
Price movement based on the high, low and last over the given period.
9.74 -51.64% decrease
on 01/07/19
-2.51 (-34.76%) decrease
since 11/15/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).